Pharmaceutical Company Essentially Creates PEP for COVID-19

Reading now: 536

Regeneron Pharmaceuticals.The antibody cocktail is given monthly, lessening the stress of a routine regimen in a place where there could be repeated exposure such as in prisons or retirement homes.Regeneron notes it is not a substitute for the COVID-19 vaccine and is not authorized to act as a pre-exposure prophylaxis to prevent the disease.“[The FDA’s] authorization enables certain people at high risk of developing severe COVID-19 infection to access REGEN-COV if they have been exposed to the virus — the first time an antibody treatment has been authorized for this purpose," said Dr.

George D. Yancopoulos, president and chief scientific officer of Regeneron. "With this authorization, the FDA specifically highlights the needs of.

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News